Form D · Pharmaceuticals

CELL THERAPEUTICS INC

Seattle, WA · CIK 0000891293

Offering snapshot reported Aug 4, 2010 · SEC filing

Reported sold: $4.06M
Investors reported: 1
Minimum accepted: $0
First sale: Jul 27, 2010

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Aug 4, 2010	Initial	$4,060,000	No comparison	1	SEC filing
Jun 4, 2010	Initial	$1,848,000	No comparison	10	SEC filing
Aug 17, 2007	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Equity, Option to acquire
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $253K
Finders' fees: $0
Form D file number: 021-145888

In addition to $203,000 in cash and $50,000 in reimbursement of expenses, Rodman & Renshaw, LLP received warrants to purchase 348,000 shares of commmon stock of Cell Therapeutics Inc.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Rodman & Renshaw, LLP	16415

Source: Form D, filed Aug 4, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
John H. Bauer	Director
Louis A. Bianco	Executive
James A. Bianco	Executive
Daniel G. Eramian	Executive
Vartan Gregorian	Director
Richard L. Love	Director
Mary O. Mundinger	Director
Phillip M. Nudelman	Director
Craig W. Philips	Executive
Jack W. Singer	Executive
Frederick W. Telling	Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

501 Elliott Avenue West Suite 400
Seattle, WA, 98119